Resistant bacteria can remain in the body for years
“These patients not only repeatedly become ill themselves, they also act as a source of infection for other people”
Fighting disease-causing bacteria becomes more difficult when antibiotics stop working. People with pre-existing conditions in particular can carry resistant germs and suffer from repeated infections for years, according to a study by the University of Basel and University Hospital Basel.
Pneumonia, urinary tract infections, sepsis: diseases like these can become fatal without antibiotics. Some bacteria have developed the ability to break down beta-lactam antibiotics like penicillins and cephalosporins, making them ineffective. Once a patient’s body has been colonized by these resistant bacteria, they can persist for a long time, reports Professor Sarah Tschudin Sutter’s research group in the scientific journal Nature Communications.
The team at the Department of Clinical Research of the University of Basel and University Hospital Basel analyzed multiple samples taken from over 70 individuals over a period of ten years. The researchers looked at a much longer period of time than previous studies and focused on older people with pre-existing conditions. Their key question: whether and how resistant Klebsiella pneumoniae and Escherichia coli bacteria in the body change over this long period and how they differ in various parts of the body.
Recurring illness
DNA analysis indicates that the bacteria initially adapt quite quickly to the conditions in the colonized parts of the body, but undergo few genetic changes thereafter. The resistant bacteria could still be detected in the patients up to nine years later. “These patients not only repeatedly become ill themselves, they also act as a source of infection for other people – a reservoir for these pathogens,” says Dr. Lisandra Aguilar Bultet, the study’s lead author.
“This is crucial information for choosing a treatment,” explains Professor Tschudin Sutter. If someone has previously been infected with resistant bacteria and later requires another course of treatment because of a new infection, there is a risk that standard antibiotics will again fail to work.
Transmission of resistance
In addition, the researchers found that in some patients, bacterial strains of the same species, as well as of different species (specifically, Klebsiella pneumoniae and Escherichia coli), share identical genetic mechanisms of resistance through what are known as mobile genetic elements (such as plasmids). The most likely explanation is that they have transmitted these elements to each other.
Hospitals use special protective measures if a patient has been infected with resistant bacteria in the past. In everyday life, however, it is difficult to reduce the risk of pathogen transmission.
These findings about the bacterial genetic diversity expected to develop in individual patients over time are a valuable basis for future studies to analyze factors found in both bacteria and patients that correlate with duration of colonization and progression from colonization to infection.
Original publication
Lisandra Aguilar-Bultet, Ana B. García-Martín, Isabelle Vock, Laura Maurer Pekerman, Rahel Stadler, Ruth Schindler, Manuel Battegay, Tanja Stadler, Elena Gómez-Sanz, Sarah Tschudin-Sutter; "Within-host genetic diversity of extended-spectrum beta-lactamase-producing Enterobacterales in long-term colonized patients"; Nature Communications, Volume 14, 2023-12-21
Original publication
Lisandra Aguilar-Bultet, Ana B. García-Martín, Isabelle Vock, Laura Maurer Pekerman, Rahel Stadler, Ruth Schindler, Manuel Battegay, Tanja Stadler, Elena Gómez-Sanz, Sarah Tschudin-Sutter; "Within-host genetic diversity of extended-spectrum beta-lactamase-producing Enterobacterales in long-term colonized patients"; Nature Communications, Volume 14, 2023-12-21
Topics
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Category:Reversible_inhibitors_of_MAO-A
Intercell announces positive results from two clinical Phase III studies supporting pediatric label extension of JE vaccine for children traveling to endemic areas

Salt consumption controls autoimmune disease - In a surprising finding, high salt consumption is found to regulate the blood-brain barrier permeability to suppress autoimmune disease development in mice
Category:Disaster_medicine
LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study
